Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 11/20 | 0.69 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.61 |
| ▸ | NOS2 | P35228 | 2/20 | 0.56 |
| ▸ | NOS3 | P29474 | 1/20 | 0.56 |
| ▸ | NOS1 | P29475 | 1/20 | 0.56 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.51 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11575012 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL18832137 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL2367840 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL2367837 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL18832141 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL18832139 | 0.98 | BHMT (0.70) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL60520 | 0.94 | BHMT (0.66) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL4955426 | 0.94 | BHMT (0.66) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL1285565 | 0.94 | BHMT (0.66) | BHMTBHMT2NOS2NOS3NOS1 | |
| SCHEMBL28251120 | 0.89 | BHMT (0.59) | BHMTBHMT2NOS2NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106795511-B | Oxidase, polynucleotide encoding the same, and use thereof | 住友化学株式会社 | 2020-02-11 | — | — | CN | disclosed |
| CN-106661571-B | Oxidase, polynucleotide encoding the same, and use thereof | 住友化学株式会社 | 2019-12-20 | — | — | CN | disclosed |
| EP-3168301-B1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE | SUMITOMO CHEMICAL CO (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-10364448-B2 | Method for producing L-α-amino acid compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-30 | — | — | US | disclosed |
| US-10351829-B2 | Oxidase, polynucleotide that codes for same, and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-16 | — | — | US | disclosed |
| EP-3492477-A1 | BORON-CONTAINING COMPOUND | Stella Pharma Corporation (JP) | 2019-06-05 | — | — | EP | disclosed |
| US-20170191097-A1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-06 | — | — | US | disclosed |
| US-20170159029-A1 | OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3168301-A1 | OXIDASE, POLYNUCLEOTIDE ENCODING SAME, AND USE OF THESE | Sumitomo Chemical Company, Limited (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-3168302-A1 | OXIDASE, POLYNUCLEOTIDE THAT CODES FOR SAME, AND USES FOR BOTH | Sumitomo Chemical Company, Limited (JP) | 2017-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351829-B2 | Oxidase, polynucleotide that codes for same, and use thereof | DAO, PNPO, HAO1 | BHMT 909/4885BHMT2 1493/4885NOS2 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.